PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2015.2952018332432-434Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumorEunjung Yim, Ho Jung An, Uiju Cho, Youngwoo Kim, Seung Hoon Kim, Yeon-Geun Choi, Byoung Yong Shimhttp://kjim.org/upload/kjim-2015-295.pdf, http://kjim.org/journal/view.php?doi=10.3904/kjim.2015.295, http://www.kjim.org/upload/kjim-2015-295.pdf
Annals of Oncology10.1093/annonc/mdz026.003201930i13Clinical correlation between different CKIT exon mutations and clinical outcome imatinib mesylate treatment in gastrointestinal stromal tumor (GIST) patientsG.Y. Zakaria, N. Allahloubi, A. Bahnasy, O. Khorshidhttps://api.elsevier.com/content/article/PII:S0923753419300067?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419300067?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/30/Supplement_1/mdz026.003/27978710/mdz026.003.pdf
Cancer Chemotherapy and Pharmacology10.1007/s00280-004-0886-y2004Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors?a reviewAkira Sawaki, Kenji Yamaohttp://link.springer.com/content/pdf/10.1007/s00280-004-0886-y.pdf, http://link.springer.com/article/10.1007/s00280-004-0886-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-004-0886-y
Nature Clinical Practice Oncology10.1038/ncponc0549200638411-411Effect of KIT mutations on response to imatinib in gastrointestinal stromal tumorshttp://www.nature.com/articles/ncponc0549, http://www.nature.com/articles/ncponc0549.pdf, http://www.nature.com/articles/ncponc0549.pdf
Pathology Oncology Research10.1007/bf0303370820039113-19Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with imatinibMv Chandu de Silva, Robin Reidhttp://link.springer.com/content/pdf/10.1007/BF03033708.pdf, http://link.springer.com/article/10.1007/BF03033708/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03033708
Gastroenterology10.1016/s0016-5085(98)70571-219981144629-630Gastrointestinal stromal tumors have c-kit mutationsDan Gordonhttps://api.elsevier.com/content/article/PII:S0016508598705712?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508598705712?httpAccept=text/plain
Gastrointestinal Stromal Tumors10.1007/978-3-319-42632-7_142016187-208Multimodality Therapy for Metastatic Gastrointestinal Stromal TumorDavid A. Mahvi, Emily Z. Keung, Chandrajit P. Rauthttp://link.springer.com/content/pdf/10.1007/978-3-319-42632-7_14
Clinical Sarcoma Research10.1186/2045-3329-2-23201221Management of imatinib-associated skin rash in a patient with metastatic gastrointestinal stromal tumor: a case reportJean-Yves Blayhttp://link.springer.com/content/pdf/10.1186/2045-3329-2-23.pdf, http://link.springer.com/article/10.1186/2045-3329-2-23/fulltext.html, http://link.springer.com/content/pdf/10.1186/2045-3329-2-23.pdf
Yeungnam University Journal of Medicine10.12701/yujm.2019.001152019362155-158Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumorMin Kyu Kang, Heon Ju Lee, Joon Hyuk Choihttp://yujm.yu.ac.kr/upload/pdf/yujm-2019-00115.pdf, http://yujm.yu.ac.kr/journal/view.php?doi=10.12701/yujm.2019.00115, http://www.e-yujm.org/upload/pdf/yujm-2019-00115.pdf
BMC Cancer10.1186/1471-2407-4-74200441Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case reportBrett Hughes, Desmond Yip, David Goldstein, Paul Waring, Victoria Beshay, Guan Chonghttp://link.springer.com/content/pdf/10.1186/1471-2407-4-74.pdf, http://link.springer.com/article/10.1186/1471-2407-4-74/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-4-74